https://www.healthdirect.gov.au/medicines/brand/amt,277948001000036102/fingolimod-dr-reddy-s
Fingolimod (Dr. Reddy's) | healthdirect
On this page about Fingolimod (Dr. Reddy's) you will find information relating to side effects, age restrictions, food interactions, whether the medicine is...
dr reddy sfingolimodhealthdirect
https://www.doccheck.com/de/detail/articles/2905-fingolimod-wirkstoff-weckt-viren
Fingolimod: Wirkstoff weckt Viren - DocCheck
Erhalten MS-Patienten das Immunsuppressivum Fingolimod, kommt es zur Reaktivierung von JC-Viren. Die Folge: multifokale Leukenzephalopathien als potenziell...
fingolimodwirkstoffvirendoccheck
https://www.cochrane.org/de/evidence/CD009371_fingolimod-relapsing-remitting-multiple-sclerosis
Fingolimod bei rezidivierend-remittierender multipler Sklerose | Cochrane
fingolimodbeisklerosecochrane
https://www.sciencedaily.com/releases/2015/07/150706103829.htm
Fingolimod in relapsing remitting multiple sclerosis: Indication of added benefit in certain...
Based on new analyses conducted by the drug manufacturer, an advantage can be determined in two instead of only one patient group for the use of Fingolimod in...
relapsing remittingmultiple sclerosisadded benefitfingolimod
https://www.rti.org/publication/cost-effectiveness-natalizumab-vs-fingolimod-treatment-relapsing-remitting-multiple-sclerosis
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple...
Objective:To assess the cost-effectiveness of natalizumab vs fingolimod over 2 years in relapsing-remitting multiple sclerosis (RRMS) patients and patients...
cost effectiveness
https://www.nice.org.uk/guidance/prioritisation/gid-ta10336
Project information | Fingolimod for treating relapsing multiple sclerosis in children and young...
Fingolimod for treating relapsing multiple sclerosis in children and young people [ID1378]
relapsing multiple sclerosisproject information
https://www.medicines.org.uk/emc/product/13502/smpc
Fingolimod Glenmark 0.5 mg hard capsules - Summary of Product Characteristics (SmPC) - (emc) | 13502
Fingolimod Glenmark 0.5 mg hard capsules - Summary of Product Characteristics (SmPC) by Glenmark Pharmaceuticals Europe Ltd
https://www.medicines.org.uk/emc/product/13824/xpil/print
Fingolimod 0.5mg hard capsules - XML Patient Information Leaflet (XPIL) - print friendly - (emc)
Fingolimod 0.5mg hard capsules - XML Patient Information Leaflet (XPIL) by Zentiva - print friendly
patient information leaflet